Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.365 | 5.75565831102 | 41.09 | 45.44 | 39.33 | 1107780 | 40.51330011 | CS |
| 4 | -11.695 | -21.2058023572 | 55.15 | 61.59 | 39.33 | 1127803 | 48.59415716 | CS |
| 12 | -11.12 | -20.3756298672 | 54.575 | 71.71 | 39.33 | 1153539 | 54.69953226 | CS |
| 26 | -1.055 | -2.37025387553 | 44.51 | 71.71 | 34.5125 | 826614 | 51.23651226 | CS |
| 52 | 33.645 | 342.966360856 | 9.81 | 71.71 | 7.79 | 842705 | 48.40725767 | CS |
| 156 | 29.475 | 210.836909871 | 13.98 | 71.71 | 5.65 | 344041 | 41.83178829 | CS |
| 260 | 9.455 | 27.8088235294 | 34 | 71.71 | 5.65 | 316265 | 40.15341947 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
